Association Between Serum Uric Acid and Metabolic Syndrome: a Cross-sectional Study in Bangladeshi Adults

Overview

Journal Sci Rep

Specialty Science

Date 2020 May 14

PMID 32398834

Citations 70

Authors

Nurshad Ali

Rakib Miah

Mahmudul Hasan

Zitu Barman

Ananya Dutta Mou

Jaasia Momtahena Hafsa

Aporajita Das Trisha

Akibul Hasan

Farjana Islam

Affiliations

Soon will be listed here.

Abstract

Elevated levels of serum uric acid (SUA) have been suggested to associate with cardiovascular disease, diabetes and metabolic syndrome (MetS). However, information is limited on the association between SUA and MetS in general adults. This study aimed to assess the relationship of SUA with MetS and its components in general adults in Bangladesh. A total of 420 participants were enrolled in this study and biochemical parameters including SUA, fasting blood glucose (FBG) and lipid profile were analyzed using standard methods. The NECP criteria were applied to define MetS. The association of SUA with MetS and its components were evaluated by multinomial logistic regression models. The overall prevalence of MetS was 22% with 21.9% in males and 22.1% in female participants. Male subjects had a high prevalence of elevated components of MetS than in the female subjects (p < 0.05 for all cases). The mean concentration of SUA was significantly higher in subjects of the MetS group compared to the non-MetS group (p < 0.05). The components of MetS were raised with the increasing concentrations of SUA across the quartiles. In regression analysis, SUA was significantly associated with the prevalence of MetS in Bangladeshi adults. In conclusion, elevated SUA was significantly associated with the prevalence of MetS and its components.

Citing Articles

The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007-2018).

Zhu M, Wang X, Peng Z, Yan W, Deng Q, Li M Ren Fail. 2025; 47(1):2441398.

PMID: 39910828 PMC: 11803761. DOI: 10.1080/0886022X.2024.2441398.

Investigating the prevalence and associated factors of elevated liver enzymes and dyslipidemia during pregnancy.

Mou A, Ali N Sci Rep. 2025; 15(1):3967.

PMID: 39893319 PMC: 11787354. DOI: 10.1038/s41598-025-88798-4.

Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease in Non-obese Young Population: A Prospective Cohort Study.

Li Y, Ma X, Cui S, Jiang G, Jia J, Ge X Dig Dis Sci. 2024; 70(2):825-834.

PMID: 39719467 DOI: 10.1007/s10620-024-08808-9.

Impact of high-sensitivity C-reactive protein on metabolic syndrome in an elderly population: Findings from a hospital-based cross-sectional study in J&K, India.

Masoodi A, Khuroo S J Family Med Prim Care. 2024; 13(10):4173-4180.

PMID: 39629444 PMC: 11610817. DOI: 10.4103/jfmpc.jfmpc_888_23.

Association between Body Mass Index and Serum Uric Acid: mediation analysis involving liver enzymes indicators.

Deng F, Wang Q, Wen X, Xu X, Jia L, He H BMC Public Health. 2024; 24(1):3007.

PMID: 39478457 PMC: 11526625. DOI: 10.1186/s12889-024-20457-1.

References

Grundy S . Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92(2):399-404. DOI: 10.1210/jc.2006-0513. View

Wilson P, DAgostino R, Parise H, Sullivan L, Meigs J . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112(20):3066-72. DOI: 10.1161/CIRCULATIONAHA.105.539528. View

Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan D . Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol. 2006; 47(8):1595-602. DOI: 10.1016/j.jacc.2005.12.046. View

Dekker J, Girman C, Rhodes T, Nijpels G, Stehouwer C, Bouter L . Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005; 112(5):666-73. DOI: 10.1161/CIRCULATIONAHA.104.516948. View

Fu C, Wu D, Wang J, Yang W, Tseng C . Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetol. 2008; 46(2):127-34. DOI: 10.1007/s00592-008-0069-0. View

Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L . Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol. 2010; 49 Suppl 1:S65-71. DOI: 10.1007/s00592-010-0205-5. View

Ramakrishna V, Jailkhani R . Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol. 2007; 45(1):41-6. DOI: 10.1007/s00592-007-0018-3. View

Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S . Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS One. 2018; 13(11):e0206850. PMC: 6211757. DOI: 10.1371/journal.pone.0206850. View

Ishizaka N, Ishizaka Y, Toda A, Tani M, Koike K, Yamakado M . Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals. J Rheumatol. 2009; 37(2):410-6. DOI: 10.3899/jrheum.090736. View

10.

Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H . Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013; 288(38):27138-27149. PMC: 3779712. DOI: 10.1074/jbc.M113.485094. View

11.

Chowdhury M, Anik A, Farhana Z, Bristi P, Abu Al Mamun B, Uddin M . Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. BMC Public Health. 2018; 18(1):308. PMC: 5833131. DOI: 10.1186/s12889-018-5209-z. View

12.

Glantzounis G, Tsimoyiannis E, Kappas A, Galaris D . Uric acid and oxidative stress. Curr Pharm Des. 2005; 11(32):4145-51. DOI: 10.2174/138161205774913255. View

13.

Cicero A, Fogacci F, Giovannini M, Grandi E, Rosticci M, DAddato S . Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study. Sci Rep. 2018; 8(1):11529. PMC: 6070523. DOI: 10.1038/s41598-018-29955-w. View

14.

Li Y, Chen S, Shao X, Guo J, Liu X, Liu A . Association of uric acid with metabolic syndrome in men, premenopausal women and postmenopausal women. Int J Environ Res Public Health. 2014; 11(3):2899-910. PMC: 3987011. DOI: 10.3390/ijerph110302899. View

15.

Meshkani R, Zargari M, Larijani B . The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetol. 2010; 48(1):79-88. DOI: 10.1007/s00592-010-0231-3. View

16.

Nagahama K, Inoue T, Kohagura K, Ishihara A, Kinjo K, Ohya Y . Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens Res. 2013; 37(3):232-8. DOI: 10.1038/hr.2013.137. View

17.

Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K . Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens. 2001; 19(7):1209-15. DOI: 10.1097/00004872-200107000-00005. View

18.

Ali N, Mahmood S, Islam F, Rahman S, Haque T, Islam S . Relationship between serum uric acid and hypertension: a cross-sectional study in Bangladeshi adults. Sci Rep. 2019; 9(1):9061. PMC: 6588567. DOI: 10.1038/s41598-019-45680-4. View

19.

Ali N, Rahman S, Islam S, Haque T, Molla N, Sumon A . The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019; 19(1):42. PMC: 6385393. DOI: 10.1186/s12872-019-1026-2. View

20.

Rahman S, Islam S, Haque T, Kathak R, Ali N . Association between serum liver enzymes and hypertension: a cross-sectional study in Bangladeshi adults. BMC Cardiovasc Disord. 2020; 20(1):128. PMC: 7066737. DOI: 10.1186/s12872-020-01411-6. View